Regulation of Biotechnological Risks in a Multi-Level System
An Analysis of the EU Regulation of Genome Edited Plants in light of WTO Law and CETA
Buch in deiner Nähe kaufen
Beschreibung
This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EU's opt-out mechanism and its application to genome edited plants are compatible with the EU's obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA. Based on this analysis, the EU Commission's proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commission's proposal. The book's analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.
This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EU's opt-out mechanism and its application to genome edited plants are compatible with the EU's obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA. Based on this analysis, the EU Commission's proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commission's proposal. The book's analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.
Provides a comprehensive overview of the EU regulation of genome edited plants Analyses in detail the compatibility of the EU regulation of genome edited plants with WTO law and CETA Discusses the EU Commission's proposal on plants produced by new genomic techniques and its practical implications
Autor*in
Elisabeth Anna Lümkea Andersen
Themen in »Regulation of Biotechnological Risks in a Multi-Level System«
biotechnology genome editing genome edited plants WTO law SPS Agreement TBT Agreement CETA new genomic techniques GMO authorisation procedures for GMOs labelling requirements for GMOs